Chemotherapy sensitizes colon cancer initiating cells to Vγ9Vδ2 T cell-mediated cytotoxicity.
Colon cancer comprises a small population of cancer initiating stem cells (CIC) that is responsible for tumor maintenance and resistance to anti-cancer therapies, possibly allowing for tumor recapitulation once treatment stops. Combinations of immune-based therapies with chemotherapy and other anti-...
Guardado en:
Autores principales: | Matilde Todaro, Valentina Orlando, Giuseppe Cicero, Nadia Caccamo, Serena Meraviglia, Giorgio Stassi, Francesco Dieli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6aa19933711648bb8230a8a26df4a6b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas.
por: Adriana Cordova, et al.
Publicado: (2012) -
The human Vδ2+ T-cell compartment comprises distinct innate-like Vγ9+ and adaptive Vγ9- subsets
por: Martin S. Davey, et al.
Publicado: (2018) -
Listeria monocytogenes-infected human monocytic derived dendritic cells activate Vγ9Vδ2 T cells independently of HMBPP production
por: Alejandro F. Alice, et al.
Publicado: (2021) -
The ATP-binding cassette transporter A1 regulates phosphoantigen release and Vγ9Vδ2 T cell activation by dendritic cells
por: Barbara Castella, et al.
Publicado: (2017) -
IL-4-Producing Vγ1+/Vδ6+ γδ T Cells Sustain Germinal Center Reactions in Peyer’s Patches of Mice
por: Leon Ullrich, et al.
Publicado: (2021)